
Sign up to save your podcasts
Or


This weeks episode is all about our newly launched Cannabis research nonprofit called the Network of Applied Pharmacognosy (NAP). Miyabe and I co-founded this non-profit to expand the community's voice in scientific research surrounding cannabis and other natural medicines. We currently have 2 studies underway and we just published our first paper on CBG use for anxiety.
TODAY we released what we hope to be the largest and more depth cannabis survey that will help guide us towards future studies needed in our community.
LINK TO PARTICIPATE IN STUDY:
https://btstudi.es/q/napbaseline/
LINK TO OUR WEBSITE & PRESS RELEASE:
https://appliedpharmacognosy.org/
PATREON:
https://www.patreon.com/cannabichem
THANKS FOR LISTENING, MAD LOVE
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Riley D. Kirk, Ph.D.5
8181 ratings
This weeks episode is all about our newly launched Cannabis research nonprofit called the Network of Applied Pharmacognosy (NAP). Miyabe and I co-founded this non-profit to expand the community's voice in scientific research surrounding cannabis and other natural medicines. We currently have 2 studies underway and we just published our first paper on CBG use for anxiety.
TODAY we released what we hope to be the largest and more depth cannabis survey that will help guide us towards future studies needed in our community.
LINK TO PARTICIPATE IN STUDY:
https://btstudi.es/q/napbaseline/
LINK TO OUR WEBSITE & PRESS RELEASE:
https://appliedpharmacognosy.org/
PATREON:
https://www.patreon.com/cannabichem
THANKS FOR LISTENING, MAD LOVE
Learn more about your ad choices. Visit megaphone.fm/adchoices

38,749 Listeners

574 Listeners

5,000 Listeners

42 Listeners

1,840 Listeners

705 Listeners

2 Listeners

12 Listeners

123 Listeners

50 Listeners

135 Listeners

345 Listeners

3 Listeners

41 Listeners

231 Listeners

41 Listeners

114 Listeners

129 Listeners

944 Listeners

311 Listeners

14 Listeners

33 Listeners

0 Listeners

0 Listeners

0 Listeners

3 Listeners

14 Listeners

0 Listeners

6 Listeners

0 Listeners

3 Listeners